DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BENDROFLUMETHIAZIDE; NADOLOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENDROFLUMETHIAZIDE; NADOLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
6-THIOGUANINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
6-THIOGUANINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRASTUZUMAB-ANNS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-ANNS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPIOLACTONE
4
Small molecule
Approved
OTHER
IRRIGATION
Unknown
Unknown
PROPIOLACTONE
×
Maximum Phase:
4
First Approval:
None
UNII:
6RC3ZT4HB0
Molecule Type:
Small molecule
Molecular Formula:
C3H4O2
Molecular Weight:
72.06
AlogP:
-0.07
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
0.0
Source:
TRELAGLIPTIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
TRELAGLIPTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Q836OWG55H
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O2
Molecular Weight:
357.39
AlogP:
0.53
PSA:
97.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FERROUS FUMARATE
4
Small molecule
Approved
OTHER
ORAL
Helicobacter Infections; HIV Infections; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
Supplement
FERROUS FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R5L488RY0Q
Molecule Type:
Small molecule
Molecular Formula:
C4H2FeO4
Molecular Weight:
169.9
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BESIFOVIR DIPIVOXIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BESIFOVIR DIPIVOXIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VERNAKALANT
4
Small molecule
Approved
Unknown
Unknown
Atrial Flutter; Atrial Fibrillation; Arrhythmias, Cardiac
Unknown
VERNAKALANT
×
Maximum Phase:
4
First Approval:
None
UNII:
9G468C8B13
Molecule Type:
Small molecule
Molecular Formula:
C20H31NO4
Molecular Weight:
349.47
AlogP:
2.64
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MERSALYL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MERSALYL
×
Maximum Phase:
4
First Approval:
None
UNII:
5X1IO031V8
Molecule Type:
Small molecule
Molecular Formula:
C13H16HgNNaO6
Molecular Weight:
505.85
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MAGNESIUM ASPARTATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MAGNESIUM ASPARTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R17X820ROL
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARZOXIFENE
4
Small molecule
Approved
Unknown
Unknown
Osteoporosis; Breast Neoplasms; Osteoporosis, Postmenopausal
Estrogen receptor modulator
ARZOXIFENE
×
Maximum Phase:
4
First Approval:
None
UNII:
E569WG6E60
Molecule Type:
Small molecule
Molecular Formula:
C28H29NO4S
Molecular Weight:
475.61
AlogP:
6.94
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DIETHYLTOLUAMIDE
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
DIETHYLTOLUAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
FB0C1XZV4Y
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO
Molecular Weight:
191.27
AlogP:
2.48
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ASPIRIN; METHOCARBAMOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; METHOCARBAMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZARONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BENZARONE
×
Maximum Phase:
4
First Approval:
None
UNII:
23ZW4BG89C
Molecule Type:
Small molecule
Molecular Formula:
C17H14O3
Molecular Weight:
266.3
AlogP:
3.93
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PYROVALERONE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Monoamine transporters; Norepinephrine & dopamine inhibitor
PYROVALERONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Z95Z9C2201
Molecule Type:
Small molecule
Molecular Formula:
C16H24ClNO
Molecular Weight:
281.83
AlogP:
3.44
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DIHYDROSTREPTOMYCIN
4
Small molecule
Approved
Unknown
Unknown
Eye Infections
Unknown
DIHYDROSTREPTOMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
P2I6R8W6UA
Molecule Type:
Small molecule
Molecular Formula:
C21H41N7O12
Molecular Weight:
583.6
AlogP:
-7.95
PSA:
334.59
HBD:
15.0
HBA:
#RotB:
9.0
Source:
SATIVEX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SATIVEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METAMIZOLE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
METAMIZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEUROBLOC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
NEUROBLOC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARGIPRESSIN TANNATE
4
Protein
Approved
Unknown
Unknown
Unknown
Vasopressin receptor agonist
ARGIPRESSIN TANNATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALMITRINE MESYLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ALMITRINE MESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6RY6V6XM8T
Molecule Type:
Small molecule
Molecular Formula:
C28H37F2N7O6S2
Molecular Weight:
669.78
AlogP:
4.26
PSA:
69.21
HBD:
2.0
HBA:
#RotB:
10.0
Source:
MOXISYLYTE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases; Erectile Dysfunction
Adrenergic receptor alpha antagonist
MOXISYLYTE
×
Maximum Phase:
4
First Approval:
None
UNII:
PW8QYA7KI0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
2.98
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLEBOPRIDE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Dopamine D2 receptor antagonist
CLEBOPRIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
I0A84520Y9
Molecule Type:
Small molecule
Molecular Formula:
C20H24ClN3O2
Molecular Weight:
373.88
AlogP:
3.33
PSA:
67.59
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LOBEGLITAZONE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
LOBEGLITAZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
MY89F08K5D
Molecule Type:
Small molecule
Molecular Formula:
C24H24N4O5S
Molecular Weight:
480.55
AlogP:
3.69
PSA:
102.88
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ALCOHOL; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ALCOHOL; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTARABINE; DAUNORUBICIN
4
Combination
Approved
Unknown
INTRAVENOUS
Unknown
Unknown
CYTARABINE; DAUNORUBICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUORODEOXYPHENYLALANINE
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
FLUORODEOXYPHENYLALANINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
256
257
258
259
260
261
262
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA